Patterns of response to repetitive transcranial magnetic stimulation (rTMS) in major depression: Replication study in drug-free patients

Journal of Affective Disorders

Volumn 108, Issue 1-2, 2008, Pages 59-70

  Brakemeier, Eva Lotta ^a,e   Wilbertz, Gregor ^b   Rodax, Silke ^c   Danker Hopfe, Heidi ^a   Zinka, Bettina ^c   Zwanzger, Peter ^d   Grossheinrich, Nicola ^c   Várkuti, Bálint ^b   Rupprecht, Rainer ^c   Bajbouj, Malek ^a   Padberg, Frank ^c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d UNIVERSITY OF MÜNSTER   (Germany)

^e UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Major depressive disorder; Repetitive transcranial magnetic stimulation; Response prediction; rTMS; Therapy resistance

Indexed keywords

ADULT; AGITATION; ARTICLE; CONTROLLED STUDY; FEMALE; GROWTH RETARDATION; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PREFRONTAL CORTEX; PRIORITY JOURNAL; REGRESSION ANALYSIS; TRANSCRANIAL MAGNETIC STIMULATION;

ADULT; BIPOLAR DISORDER; CLINICAL TRIALS AS TOPIC; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER, MAJOR; DOMINANCE, CEREBRAL; DRUG RESISTANCE; FEMALE; GERMANY; HUMANS; MALE; META-ANALYSIS AS TOPIC; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; PERSONALITY INVENTORY; PREFRONTAL CORTEX; PSYCHOMETRICS; RECURRENCE; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 40949093453     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2007.09.007     Document Type: Article

References (70)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR. 4th ed. (1994), American Psychiatric Publishing, Arlington, VA
2. Angst J., Scheidegger P., and Stabl M. Efficacy of moclobemide in different patient groups. Results of new subscales of the Hamilton Depression Rating Scale. Clin. Neuropharmacol. 16 (1993) 55-62
3. Bajbouj M., Brakemeier E.L., Schubert F., Lang U.E., Neu P., Schindowski C., and Danker-Hopfe H. Repetitive transcranial magnetic stimulation of the dorsolateral prefrontal cortex and cortical excitability in patients with major depressive disorder. Exp. Neurol. 196 (2005) 332-338
4. Berman R.M., Narasimhan M., Sanacora G., Miano A.P., Hoffman R.E., Hu X.S., Charney D.S., and Boutros N.N. A randomized clinical trial of repetitive transcranial magnetic stimulation in the treatment of major depression. Biol. Psychiatry 47 (2000) 332-337
5. Brakemeier E.L., Luborzewski A., Danker-Hopfe H., Kathmann N., and Bajbouj M. Positive predictors for antidepressive response to prefrontal repetitive transcranial magnetic stimulation (rTMS). J. Psychiatr. Res. 41 (2007) 395-403
6. Bschor T., Canata B., Mueller-Oerlinghausen B., and Bauer M. Predictors of response to lithium augmentation in tricyclic antidepressant-resistant depression. J. Affect. Disord. 64 (2001) 261-265
7. Buchan H., Johnstone E., McPherson K., Palmer R.L., Crow T.J., and Brandon S. Who benefits from electroconvulsive therapy? Combined results of the Leicester and Northwick Park trials. Br. J. Psychiatry 160 (1992) 355-359
8. Burt T., Lisanby S.H., and Sackeim H.A. Neuropsychiatric applications of transcranial magnetic stimulation: a meta analysis. Int. J. Neuropsychopharmacol. 5 (2002) 73-103
9. Conca A., Swoboda E., Konig P., Koppi S., Beraus W., Kunz A., Fritzsche H., and Weiss P. Clinical impacts of single transcranial magnetic stimulation (sTMS) as an add-on therapy in severely depressed patients under SSRI treatment. Hum. Psychopharmacol. 15 (2000) 429-438
10. de Vreede I.M., Burger H., and van Vliet I.M. Prediction of response to ECT with routinely collected data in major depression. J. Affect. Disord. 86 (2005) 323-327
11. Dombrovski A.Y., Mulsant B.H., Haskett R.F., Prudic J., Begley A.E., and Sackeim H.A. Predictors of remission after electroconvulsive therapy in unipolar major depression. J. Clin. Psychiatry 66 (2005) 1043-1049
12. Eschweiler G.W., Plewnia C., and Bartels M. Welche depressiven Patienten profitieren von präfrontaler repetitiver transkranieller Magnetstimulation (rTMS)?. Fortschr. Neurol. Psychiatr. 69 (2001) 402-409
13. Figiel G.S., Epstein C., McDonald W.M., Mazon-Leece J., Figiel L., Saldivia A., and Glover S. The use of rapid-rate transcranial magnetic stimulation (rTMS) in refractory depressed patients. J. Neuropsychiatry Clin. Neurosci. 10 (1998) 20-25
14. Fitzgerald P.B., Brown T.L., Marston N.A., Daskalakis Z.J., de Castella A., and Kulkarni J. Transcranial megnetic stimulation in the treatment of depression. Arch. Gen. Psychiatry 60 (2003) 1002-1008
15. Fregni F., Marcolin M.A., Myczkowski M., Amiaz R., Hasey G., Rumi D.O., Rosa M., Rigonatti S.P., Camprodon J., Walpoth M., Heaslip J., Grunhaus L., Hausmann A., and Pascual-Leone A. Predictors of antidepressant response in clinical trials of transcranial magnetic stimulation. Int. J. Neuropsychopharmacol. 9 (2006) 641-654
16. Gelenberg A.J., Kocsis J.H., McCullough Jr. J.P., Ninan P.T., and Thase M.E. The state of knowledge of chronic depression. J. Clin. Psychiatry 67 (2006) 179-184
17. Gershon A.A., Dannon P.N., and Grunhaus L. Transcranial magnetic stimulation in the treatment of depression. Am. J. Psychiatry 160 (2003) 835-845
18. Grunhaus L., Dannon P.N., Schreiber S., Dolberg O.H., Amiaz R., Ziv R., and Lefkifker E. Repetitive transcranial magnetic stimulation is as effective as electroconvulsive therapy in the treatment of nondelusional major depressive disorder: an open study. Biol. Psychiatry 47 (2000) 314-324
19. Grunhaus L., Schreiber S., Dolberg O.H., Polak D., and Dannon P.N. A randomized controlled comparison of electroconvulsive therapy and repetitive transcranial magnetic stimulation in severe and resistant nonpsychotic major depression. Biol. Psychiatry 53 (2003) 324-331
20. Hadzi-Pavlovic D., Hickie I., Brodaty H., Boyce P., Mitchell P., Wilhelm K., and Parker G. Inter-rater reliability of a refined index of melancholia: the CORE system. J. Affect. Disord. 27 (1993) 155-162
21. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23 (1960) 56-62
22. Herrmann L.L., and Ebmeier K.P. Factors modifying the efficacy of transcranial magnetic stimulation in the treatment of depression: a review. J. Clin. Psychiatry 67 (2006) 1870-1876
23. Herwig U., Schoenfeldt-Lecuona C., Wunderlich A.P., von Tiesenhausen C., Thielscher A., Walter H., and Spitzer M. The navigation of transcranial magnetic stimulation. Psychiatry Res. 108 (2001) 123-131
24. Herwig U., Padberg F., Unger J., Spitzer M., and Schoenfeldt-Lecuona C. Transcranial magnetic stimulation in therapy studies: examination of the reliability of standard coil positioning by neuronavigation. Biol. Psychiatry 50 (2001) 58-61
25. Hickie I., Mason C., Parker G., and Brodaty H. Prediction of ECT response: validation of a refined sign-based (CORE) system for defining melancholia. Br. J. Psychiatry 169 (1996) 68-74
26. Hirschfeld R.M., Montgomery S.A., Keller M.B., Kasper S., Schatzberg A.F., Moeller H.J., Healy D., Baldwin D., Humble M., Versiani M., Montenegro R., and Bourgeois M. Social functioning in depression: a review. J. Clin. Psychiatry 61 (2000) 268-275
27. Hoflich G., Kasper S., Hufnagel S., Ruhrmann S., and Moeller H. Application of transcranial magnetic stimulation in treatment of drug-resistant major depression: a report of two cases. Hum. Psychopharmacol. 8 (1993) 361-365
28. Holtzheimer III P.E., Russo J., Claypoole K.H., Roy-Byrne P., and Avery D.H. Shorter duration of depressive episode may predict response to repetitive transcranial magnetic stimulation. Depress. Anxiety 19 (2004) 24-30
29. Huang C.C., Su T.P., and Wei I.H. Repetitive transcranial magnetic stimulation for treating medication-resistant depression in Taiwan: a preliminary study. J. Chin. Med. Assoc. 68 (2005) 210-215
30. Janicak P.G., and Martis B. Strategies for treatment-resistant depression. Clin. Cornerstone 1 (1999) 58-71
31. Janicak P.G., Davis J.M., Gibbons R.D., Ericksen S., Chang S., and Gallagher P. Efficacy of ECT: a meta-analysis. Am. J. Psychiatry 142 (1985) 297-302
32. Keck Jr. P.E., Welge J.A., McElroy S.L., Arnold L.M., and Strakowski S.M. Placebo effect in randomized, controlled studies of acute bipolar mania and depression. Biol. Psychiatry 47 (2000) 748-755
33. Keck M.E., Welt T., Mueller M.B., Erhardt A., Ohl F., Toschi N., Holsboer F., and Sillaber I. Repetitive transcranial magnetic stimulation increases the release of dopamine in the mesolimbic and mesostriatal system. Neuropharmacol. 43 (2002) 101-109
34. Kozel F.A., Nahas Z., deBrux C., Molloy M., Lorberbaum J.P., Bohning D., Risch S.C., and George M.S. How coil-cortex distance relates to age, motor threshold, and antidepressant response to repetitive transcranial magnetic stimulation. J. Neuropsychiatry Clin. Neurosci. 12 (2000) 376-384
35. Lisanby S.H., and Belmaker R.H. Animal models of the mechanisms of action of repetitive transcranial magnetic stimulation (RTMS): comparisons with electroconvulsive shock (ECS). Depress. Anxiety 12 (2000) 178-187
36. Lisanby S.H., Gutman D., Luber B., Schroeder C., and Sackeim H.A. Sham TMS: intracerebral measurement of the induced electrical field and the induction of motor-evoked potentials. Biol. Psychiatry 49 (2001) 460-463
37. Loo C.K., and Mitchell P.B. A review of the efficacy of transcranial magnetic stimulation (TMS) treatment for depression, and current and future strategies to optimize efficacy. J. Affect. Disord. 88 (2005) 255-267
38. Loo C.K., Mitchell P., Sachdev P., McDarmont B., Parker G., and Gandevia S. Double-blind controlled investigation of transcranial magnetic stimulation for the treatment of resistant major depression. Am. J. Psychiatry 156 (1999) 946-948
39. Loo C.K., Taylor J.L., Gandevia S.C., McDarmont B.N., Mitchell P.B., and Sachdev P.S. Transcranial magnetic stimulation (TMS) in controlled treatment studies: are some sham forms active?. Biol. Psychiatry 47 (2000) 325-331
40. Lopez A.D., and Murray C.C. The global burden of disease: 1990-2020. Nat. Med. 4 (1998) 1241-1243
41. Manes F., Jorge R., Morcuende M., Yamada T., Paradiso S., and Robinson R.G. A controlled study of repetitive transcranial magnetic stimulation as a treatment of depression in the elderly. Int. Psychogeriatr. 13 (2001) 225-231
42. Martin J.L., Barbanoj M.J., Schlaepfer T.E., Thompson E., Perez V., and Kulisevsky J. Repetitive transcranial magnetic stimulation for the treatment of depression. Systematic review and meta-analysis. Br. J. Psychiatry 182 (2003) 480-491
43. Mayberg H.S., Silva J.A., Brannan S.K., Tekell J.L., Mahurin R.K., McGinnis S., and Jerabek P.A. The functional neuroanatomy of the placebo effect. Am. J. Psychiatry 159 (2002) 728-737
44. Milak M.S., Parsey R.V., Keilp J., Oquendo M.A., Malone K.M., and Mann J.J. Neuroanatomic correlates of psychopathologic components of major depressive disorder. Arch. Gen. Psychiatry 62 (2005) 397-408
45. Mitchell P.B., Schweitzer I., Burrows G., Johnson G., and Polonowita A. Efficacy of venlafaxine and predictors of response in a prospective open-label study of patients with treatment-resistant major depression. J. Clin. Psychopharmacol. 20 (2000) 483-487
46. Montgomery S.A., and Asberg M. A new depression scale designed to be sensitive to change. Br. J. Psychiatry 134 (1979) 382-389
47. Mosimann U.P., Schmitt W., Greenberg B.D., Kosel M., Muri R.M., Berkhoff M., Hess C.W., Fisch H.U., and Schlaepfer T.E. Repetitive transcranial magnetic stimulation: a putative add-on treatment for major depression in elderly patients. Psychiatry Res. 126 (2004) 123-133
48. Nahas Z., Li X., Kozel F.A., Mirzki D., Memon M., Miller K., Yamanaka K., Anderson B., Chae J.H., Bohning D.E., Mintzer J., and George M.S. Safety and benefits of distance-adjusted prefrontal transcranial magnetic stimulation in depressed patients 55-75 years of age: a pilot study. Depress. Anxiety 19 (2004) 249-256
49. Nelson E.C. An open-label study of nefazodone in the treatment of depression with and without comorbid obsessive compulsive disorder. Ann. Clin. Psychiatry 6 (1994) 249-253
50. Nobler M.S., Devanand D.P., Kim M.K., Fitzsimons L.M., Singer T.M., Turret N., Sackeim H.A., and Roose S.P. Fluoxetine treatment of dysthymia in the elderly. J. Clin. Psychiatry 57 (1996) 254-256
51. O'Leary D., Gill D., Gregory S., and Shawcross C. Which depressed patients respond to ECT: the Nottingham results. J. Affect. Disord. 33 (1995) 245-250
52. O'Reardon, J.P., Solvason, B., Janicak, P.G., Sampson, S., Isenberg, K.E., Nahas, Z., McDonald, W.M., Avery, D., Fitzgerald, P.B., Loo, C., Demitrack, M.A., George, M.S., Sackeim, H.A., 2007. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multi-site randomized controlled trial. Biol. Psychiatry 62 (11), 1208-1216.
53. Padberg F., Zwanzger P., Thoma H., Kathmann N., Haag C., Greenberg B.D., Hampel H., and Moeller H.J. Repetitive transcranial magnetic stimulation (rTMS) in pharmacotherapy-refractory major depression: comparative study of fast, slow, and sham rTMS. Psychiatry Res. 88 (1999) 163-171
54. Padberg F., Zwanzger P., Keck M.E., Kathmann N., Mikhaiel P., Ella R., Rupprecht P., Thoma H., Hampel H., Toschi N., and Moeller H.J. Repetitive transcranial magnetic stimulation (rTMS) in major depression: relation between efficacy and stimulation intensity. Neuropsychopharmacology 27 (2002) 638-645
55. Padberg F., Grossheinrich N., Pogarell O., Moeller H.J., and Fregni F. Efficacy and safety of prefrontal repetitive transcranial magnetic stimulation in affective disorders. In: Marcolin M., and Padberg F. (Eds). Transcranial Brain Stimulation for Treatment of Psychiatric Disorders. Adv. Biol. Psychiatry vol. 23 (2007) 53-83 (book series)
56. Pogarell O., Koch W., Poepperl G., Tatsch K., Jakob F., Zwanzger P., Mulert C., Rupprecht R., Moeller H.J., Hegerl U., and Padberg F. Striatal dopamine release after prefrontal repetitive transcranial magnetic stimulation in major depression: preliminary results of a dynamic [123I] IBZM SPECT study. J. Psychiatr. Res. 40 (2006) 307-314
57. Prudic J., Haskett R.F., Mulsant B., Malone K.M., Pettinati H.M., Stephens S., Greenberg R., Rifas S.L., and Sackeim H.A. Resistance to antidepressant medications and short-term clinical response to ECT. Am. J. Psychiatry 153 (1996) 985-992
58. Sackeim H.A. The definition and meaning of treatment-resistant depression. J. Clin. Psychiatry 62 (2001) 10-17
59. Sackeim H.A., Rush A.J., George M.S., Marangell L.B., Husain M.M., Nahas Z., Johnson C.R., Seidman S., Giller C., Haines S., Simpson Jr. R.K., and Goodman R.R. Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharmacology 25 (2001) 713-728
60. Schlaepfer T.E., Kosel M., and Nemeroff C.B. Efficacy of repetitive transcranial magnetic stimulation (rTMS) in the treatment of affective disorders. Neuropsychopharmacology 28 (2003) 201-205
61. Schuele C., Zwanzger P., Baghai T., Mikhaiel P., Thoma H., Moeller H.J., Rupprecht R., and Padberg F. Effects of antidepressant pharmacotherapy after repetitive transcranial magnetic stimulation in major depression: an open follow-up study. J. Psychiatr. Res. 37 (2003) 145-153
62. Sobin C., Prudic J., Devanand D.P., Nobler M.S., and Sackeim H.A. Who responds to electroconvulsive therapy? A comparison of effective and ineffective forms of treatment. Br. J. Psychiatry 169 (1996) 322-328
63. Sturm R., and Wells K.B. How can care for depression become more cost-effective?. JAMA 273 (1995) 51-58
64. Su T.P., Huang C.C., and Wei I.H. Add-on rTMS for medication-resistant depression: a randomized, double-blind, sham-controlled trial in Chinese patients. J. Clin. Psychiatry 66 (2005) 930-937
65. Thielscher A., and Kammer T. Electric field properties of two commercial figure-8 coils in TMS: calculation of focality and efficiency. Clin. Neurophysiol. 115 (2004) 1697-1708
66. Thase, M.E., Rush, A.J., 1995. Treatment resistant depression. In: Bloom, F.E., Kupfer, D.J. (Eds.), Psychopharmacology: the Fourth Generation of Progress. Raven Press, New York, pp. 1081-1097.
67. Thase M.E., Reynolds III C.F., Frank E., Simons A.D., Garamoni G.G., and McGeary J. Response to cognitive behaviour therapy in chronic depression. J. Psychother. Pract. Res. 3 (1994) 204-214
68. *D: implications for clinical practice. Am. J. Psychiatry 163 (2006) 28-40
69. World Medical Association. Revising the Declaration of Helsinki. Bull. Med. Ethics 158 (2000) 9-11
70. Zwanzger P., Baghai T.C., Padberg F., Ella R., Minov C., Mikhaiel P., Schüle C., Thoma H., and Rupprecht R. The combined dexamethasone-CRH test before and after repetitive transcranial magnetic stimulation (rTMS) in major depression. Psychoneuroendocrinology 28 (2003) 376-385